Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination

Final Report: A Phase 3, Randomized, Open-Label Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Adults ≥65 Years of Age With Prior Pneumococcal Vaccination

Category & Conditions:
Vaccine-related Conditions
Medicine:
PF-06482077
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B7471006
Open Plain Language Summary Result:Click here